Business Description
The Oncology Institute Inc
NAICS : 621498
SIC : 8093
ISIN : US68236X1000
Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.16 | |||||
Debt-to-Equity | 4.14 | |||||
Debt-to-EBITDA | -2.02 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.03 | |||||
Beneish M-Score | -3.24 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.8 | |||||
3-Year EBITDA Growth Rate | -76.1 | |||||
3-Year EPS without NRI Growth Rate | -47.3 | |||||
3-Year FCF Growth Rate | -269.3 | |||||
3-Year Book Growth Rate | 20.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.8 | |||||
9-Day RSI | 40.26 | |||||
14-Day RSI | 40.13 | |||||
6-1 Month Momentum % | -70.11 | |||||
12-1 Month Momentum % | -32.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.31 | |||||
Quick Ratio | 2.99 | |||||
Cash Ratio | 1.32 | |||||
Days Inventory | 14.54 | |||||
Days Sales Outstanding | 50.54 | |||||
Days Payable | 18.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | -33.35 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 15.33 | |||||
Operating Margin % | -17.6 | |||||
Net Margin % | -19.81 | |||||
FCF Margin % | -13.29 | |||||
ROE % | -125.91 | |||||
ROA % | -34.34 | |||||
ROIC % | -49.92 | |||||
ROC (Joel Greenblatt) % | -86.97 | |||||
ROCE % | -38.46 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.08 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 5.28 | |||||
EV-to-EBIT | -1.55 | |||||
EV-to-EBITDA | -1.71 | |||||
EV-to-Revenue | 0.28 | |||||
EV-to-FCF | -2.14 | |||||
Earnings Yield (Greenblatt) % | -64.52 | |||||
FCF Yield % | -171.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TOI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Oncology Institute Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 361.067 | ||
EPS (TTM) ($) | -0.79 | ||
Beta | 0 | ||
Volatility % | 88.77 | ||
14-Day RSI | 40.13 | ||
14-Day ATR ($) | 0.056969 | ||
20-Day SMA ($) | 0.45489 | ||
12-1 Month Momentum % | -32.93 | ||
52-Week Range ($) | 0.305 - 2.655 | ||
Shares Outstanding (Mil) | 75.49 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
The Oncology Institute Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
The Oncology Institute Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
The Oncology Institute Inc Frequently Asked Questions
What is The Oncology Institute Inc(TOI)'s stock price today?
The current price of TOI is $0.37. The 52 week high of TOI is $2.66 and 52 week low is $0.31.
When is next earnings date of The Oncology Institute Inc(TOI)?
The next earnings date of The Oncology Institute Inc(TOI) is 2024-11-08 Est..
Does The Oncology Institute Inc(TOI) pay dividends? If so, how much?
The Oncology Institute Inc(TOI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |